By InvitationNot Applicable

Trajectories of FEV1 After Lung Transplantation

France2,500 participantsStarted 2020-01-01

Plain-language summary

For individuals with ESLD, lung transplantation is the best, or only treatment option with increased pulmonary function and quality of life. The forced expiratory volume in one second (FEV1) is the standard to monitor the lung function after transplantation. The goal of this study is to identify and validate the FEV1 trajectories after lung transplantation, as well as their determinants and outcomes, using an international cohort of lung recipients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Double lung transplant recipients * Age 18 years or older at the time of transplant * Transplant between January 1, 2010 and December 31, 2020 * At least 2 PFTs available for analysis Exclusion Criteria: * Did not consent to clinical data use for research purposes * Multi-organ transplant

What they're measuring

FEV1 trajectories

Timeframe: Up to 10 years after lung transplantation

Trial details

NCT IDNCT05934617

SponsorParis Translational Research Center for Organ Transplantation

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-01

View on ClinicalTrials.gov More Lung Transplant Failure and Rejection trials